Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,471 | 196 | 99.7% |
| Education | $12.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,089 | 56 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $379.10 | 14 | $0 (2024) |
| Novo Nordisk Inc | $321.37 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $314.84 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $313.32 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $219.00 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $179.51 | 5 | $0 (2022) |
| Amgen Inc. | $171.98 | 11 | $0 (2024) |
| PFIZER INC. | $163.08 | 12 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $144.11 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $956.76 | 24 | AstraZeneca Pharmaceuticals LP ($150.37) |
| 2023 | $807.99 | 29 | Bayer Healthcare Pharmaceuticals Inc. ($276.03) |
| 2022 | $922.74 | 31 | Biohaven Pharmaceutical Holding Company Ltd. ($144.11) |
| 2021 | $78.27 | 5 | AstraZeneca Pharmaceuticals LP ($39.34) |
| 2020 | $366.02 | 21 | AstraZeneca Pharmaceuticals LP ($199.54) |
| 2019 | $581.48 | 31 | AstraZeneca Pharmaceuticals LP ($276.59) |
| 2018 | $422.32 | 31 | AstraZeneca Pharmaceuticals LP ($134.76) |
| 2017 | $347.34 | 25 | AstraZeneca Pharmaceuticals LP ($123.05) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $97.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $132.39 | General |
| Category: Rare Disease | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $109.59 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $95.31 | General |
| Category: Neuropsychiatry | ||||||
| 08/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.89 | General |
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardio-renal | ||||||
| 04/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 03/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: Central Nervous System | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.25 | General |
| Category: Respiratory | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 145 | 208 | $4,784 | $1,208 |
| 2022 | 1 | 204 | 380 | $9,490 | $2,268 |
| 2021 | 5 | 347 | 670 | $54,834 | $22,406 |
| 2020 | 7 | 446 | 721 | $76,826 | $32,050 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 145 | 208 | $4,784 | $1,208 | 25.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 204 | 380 | $9,490 | $2,268 | 23.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 160 | $19,840 | $8,810 | 44.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 36 | $10,440 | $5,545 | 53.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 49 | 54 | $8,100 | $4,345 | 53.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 200 | 404 | $12,726 | $2,462 | 19.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 16 | $3,728 | $1,244 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 61 | 162 | $20,088 | $9,408 | 46.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 43 | $12,631 | $7,027 | 55.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 66 | 80 | $12,124 | $6,894 | 56.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 39 | 40 | $9,320 | $3,381 | 36.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 29 | $4,140 | $2,497 | 60.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 212 | 344 | $15,924 | $2,130 | 13.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 17 | 23 | $2,599 | $712.82 | 27.4% |
About Dr. James Pilcher, M.D
Dr. James Pilcher, M.D is a Internal Medicine healthcare provider based in Louisville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942230107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Pilcher, M.D has received a total of $4,483 in payments from pharmaceutical and medical device companies, with $956.76 received in 2024. These payments were reported across 197 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,471).
As a Medicare-enrolled provider, Pilcher has provided services to 1,142 Medicare beneficiaries, totaling 1,979 services with total Medicare billing of $57,932. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Louisville, GA
- Active Since 07/04/2006
- Last Updated 04/16/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942230107
Products in Payments
- FARXIGA (Drug) $901.68
- Kerendia (Drug) $379.10
- ELIQUIS (Drug) $179.51
- JARDIANCE (Drug) $161.80
- NURTEC ODT (Drug) $144.11
- REXULTI (Drug) $135.96
- AIRSUPRA (Drug) $135.56
- ULTOMIRIS (Biological) $132.39
- AREXVY (Drug) $128.89
- Leqembi (Drug) $125.00
- CHANTIX (Drug) $118.32
- Austedo XR (Drug) $112.20
- REMICADE (Biological) $108.16
- AUSTEDO (Drug) $102.00
- AJOVY (Drug) $99.12
- INGREZZA (Drug) $95.31
- Aimovig (Biological) $80.19
- Rybelsus (Drug) $77.44
- LEQVIO (Drug) $66.22
- TRULICITY (Drug) $66.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400